OZEM — Roundhill GLP-1 & Weight Loss ETF
Data updated: 2026-08-26
OZEM — Roundhill GLP-1 & Weight Loss ETF. Global (incl. US) Large Cap Growth Health Care Equity · $54.08M AUM. Holdings, fees, performance and SEC filings.
OZEM Fund Overview
OZEM — Roundhill GLP-1 & Weight Loss ETF is a US ETF managed by Roundhill ETF Trust, categorised as Global (incl. US) Large Cap Growth Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Roundhill ETF Trust
- Category: Global (incl. US) Large Cap Growth Health Care Equity
- Assets under management: $54.08M
- 1-year return: 30.3%
- Ticker: OZEM
- SEC CIK: 0001976517
- SEC series ID: S000085000
- Share class ID: C000249863
OZEM Holdings
Top 10 holdings of Roundhill GLP-1 & Weight Loss ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Novo Nordisk A/S | 12.96% |
| Eli Lilly & Co | 12.69% |
| Mount Vernon Liquid Assets Portfolio, LLC | 9.93% |
| Pfizer Inc | 6.38% |
| Kailera Therapeutics Inc | 6.21% |
| Viking Therapeutics Inc | 5.86% |
| CSPC Pharmaceutical Group Ltd | 5.32% |
| Chugai Pharmaceutical Co Ltd | 4.51% |
| Ascletis Pharma Inc | 4.20% |
| Zealand Pharma A/S | 3.92% |
OZEM Portfolio Allocation
Asset-class allocation of Roundhill GLP-1 & Weight Loss ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.6% |
| Cash & Equivalents | 10.6% |
OZEM Performance
Total returns for OZEM (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -5.0% |
| 1 year | 30.3% |
| 3 years (annualised) | 12.9% |
OZEM Risk Information
Risk metrics for OZEM, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 22.5%
OZEM Costs and Fees
OZEM costs about $59 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.59%
- Gross expense ratio: 0.59%
- Portfolio turnover: 66%
- Brokerage commissions: 7.40 bps of average net assets (SEC N-CEN)
OZEM Cashflows
Over the 12 months to 2026-06, Roundhill GLP-1 & Weight Loss ETF had net inflows of $13.20M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $2.77M |
| 2026-05 | −$2.48M |
| 2026-04 | $0 |
| 2026-03 | −$100.92K |
| 2026-02 | $0 |
| 2026-01 | $13.17M |
OZEM Debt Constituents
No individual debt constituents are reported in Roundhill GLP-1 & Weight Loss ETF's latest SEC N-PORT filing.
OZEM Prospectus and SEC Filings
Official Roundhill GLP-1 & Weight Loss ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-30
- Prospectus (485BPOS) — filed 2025-04-30
- Prospectus (485BPOS) — filed 2024-05-20
- Portfolio holdings (N-PORT) — filed 2026-08-26
- Portfolio holdings (N-PORT) — filed 2026-05-22
- Portfolio holdings (N-PORT) — filed 2026-02-26
- Annual census (N-CEN) — filed 2026-03-13
- Annual census (N-CEN) — filed 2025-03-14
Related Funds
Other Global (incl. US) Large Cap Growth Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.